Catheter Precision, Inc. — Director's Dealing 2023

Mar 27, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ra Medical Systems, Inc. (RMED)
CIK: 0001716621
Period of Report: 2023-01-09

Reporting Person: Meline Susanne (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-23	Common Stock	C	2575	—	Acquired	2575	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-09	Series X Convertible Preferred Stock	$0	A	14.0560	Acquired		Common Stock (14056)	Indirect
2023-03-23	Series X Convertible Preferred Stock	$0	C	2.575	Disposed		Common Stock (11481)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	36	Direct
Common Stock	800	Indirect

Footnotes

F1: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.

F2: Securities are owned by Catalysis Partners ("CP"). The reporting person has an investment interest in CP through her IRA and, together with an immediate family member, owns a controlling interest in Francis Capital Management, LLC, which also has an investment interest in CP and serves as both its Managing Member and Investment Manager. The reporting person disclaims beneficial interest of these securities except to the extent of her pecuniary interest therein.

F3: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F4: On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000).

F5: Series X Convertible Preferred Stock has no expiration date.